The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Immune infiltrates in metastatic uveal melanoma liver metastases and associations with clinical outcomes.
 
Katherine Emilie Rhoades Smith
No Relationships to Disclose
 
Sarah M. Jenkins
No Relationships to Disclose
 
Anastasios Dimou
Honoraria - Intellisphere; Intellisphere (Inst); Intellisphere (Inst); Roche/Genentech
Consulting or Advisory Role - Anheart Therapeutics; ChromaCode; Guardant Health (Inst); TP Therapeutics (Inst)
Research Funding - Anheart Therapeutics (Inst); Anheart Therapeutics (Inst); Guardant Health; Merck; Novartis (Inst); Sorrento Therapeutics (Inst); Sorrento Therapeutics (Inst); Syntrix Biosystems (Inst)
Travel, Accommodations, Expenses - Guardant Health
Other Relationship - Rising Tide Foundation (Inst)
 
Arkadiusz Z. Dudek
No Relationships to Disclose
 
Matthew Stephen Block
Research Funding - Alkermes; Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Immune Design (Inst); Marker, Inc. (Inst); Merck (Inst); nference; Pharmacyclics (Inst); Regeneron; Sorrento Therapeutics (Inst); TILT Biotherapeutics; Transgene (Inst); Viewpoint Molecular Targeting
(OPTIONAL) Uncompensated Relationships - Sorrento Therapeutics; TILT Biotherapeutics; Viewpoint Molecular Targeting
 
Svetomir Markovic
Stock and Other Ownership Interests - Sorrento Therapeutics
Consulting or Advisory Role - Sorrento Therapeutics
Research Funding - Bristol-Myers Squibb; Nektar; Sorrento Therapeutics
Patents, Royalties, Other Intellectual Property - Nanoparticles (patents); Nanoparticles - immunoconjugates
 
Robert R. McWilliams
Stock and Other Ownership Interests - Zentalis
Consulting or Advisory Role - Zentalis
Research Funding - Bristol-Myers Squibb (Inst); GlaxoSmithKline/Tesaro (Inst); Merck (Inst); Newlink Genetics (Inst)
 
Lisa A. Kottschade
Consulting or Advisory Role - Immunocore
 
Heather N Montane
No Relationships to Disclose
 
Diva Salomao
No Relationships to Disclose
 
Asad Javed
No Relationships to Disclose